Novel Polyhydroquinoline-Hydrazide-Linked Schiff's Base Derivatives: Multistep Synthesis, Antimicrobial, and Calcium-Channel-Blocking Activities.
ZainabHaitao YuNajeeb Ur RehmanMumtaz AliAftab AlamAbdul LatifNazish ShahabIrfan Amir KhanAbdul Jabbar ShahMomin KhanAhmed Al-GhafriAhmed Al HarrasiManzoor AhmadPublished in: Antibiotics (Basel, Switzerland) (2022)
Polyhydroquinoline (PHQ) are the unsymmetrical Hantzsch derivatives of 1,4-dihydropyridines with several biological applications. In this work, twenty-five ( 3 - 27 ) new Schiff's base derivatives of polyhydroquinoline hydrazide were synthesized in excellent to good yields by a multi-component reaction. The structures of the synthesized products ( 1 - 27 ) were deduced with the help of spectroscopic techniques, such as 1 H-, 13 C -NMR, and HR-ESI-MS. The synthesized products ( 1 - 27 ) were tested for their antibacterial and in vitro calcium -channel-blocking (CCB) potentials using the agar-well diffusion method, and isolated rat aortic ring preparations, respectively. Among the series, sixteen compounds were found to inhibit the growth of Escherichia coli and Enterococcus faecalis . Among them, compound 17 was observed to be the most potent one at a dose 2 µg/mL, with an 18 mm zone of inhibition against both bacteria when it was compared with the standard drug amoxicillin. Eight compounds showed CCB activity of variable potency; in particular, compound 27 was more potent, with an EC 50 value of 0.7 (0.3-1.1) µg/mL, indicating their CCB effect.
Keyphrases
- escherichia coli
- ms ms
- high resolution
- anti inflammatory
- structure activity relationship
- magnetic resonance
- oxide nanoparticles
- multiple sclerosis
- staphylococcus aureus
- mass spectrometry
- aortic valve
- molecular docking
- oxidative stress
- heart failure
- multidrug resistant
- cystic fibrosis
- biofilm formation
- adverse drug
- pulmonary hypertension
- aortic dissection
- drug induced